Balance Sheet Components - Other Accrued Liabilities (Details) - USD ($) $ in Thousands |
Jun. 30, 2025 |
Dec. 31, 2024 |
Jun. 30, 2024 |
Dec. 31, 2023 |
---|---|---|---|---|
Balance Sheet Components | ||||
Reserves for refunds to insurance carriers | $ 9,700 | $ 11,276 | $ 16,465 | $ 23,245 |
Accrued charges for third-party testing | 17,188 | 12,321 | ||
Testing and laboratory materials from suppliers | 12,522 | 7,893 | ||
Marketing and corporate affairs | 16,572 | 16,548 | ||
Legal, audit and consulting fees | 84,747 | 54,208 | ||
Accrued shipping charges | 2,545 | 1,625 | ||
Sales and income tax payable | 6,535 | 4,416 | ||
Accrued third-party service fees | 8,945 | 9,046 | ||
Clinical trials and studies | 9,604 | 10,097 | ||
Operating lease liabilities, current portion | 13,056 | 10,168 | ||
Property and equipment purchases | 7,581 | 7,098 | ||
Other accrued expenses | 2,039 | 2,197 | ||
Total other accrued liabilities | $ 191,034 | $ 146,893 |
X | ||||||||||
- Definition Carrying value as of the balance sheet date of obligations incurred through that date and payable for outsourced testing. No definition available.
|
X | ||||||||||
- Definition Carrying value as of the balance sheet date of obligations incurred through that date and payable for clinical trials and studies. No definition available.
|
X | ||||||||||
- Definition Carrying value as of the balance sheet date of obligations incurred and payable for fixed assets. No definition available.
|
X | ||||||||||
- Definition Carrying value as of the balance sheet date of obligations incurred through that date and payable for shipping charges. No definition available.
|
X | ||||||||||
- Definition Carrying value as of the balance sheet date of obligations incurred through that date and payable for specimen service fees. No definition available.
|
X | ||||||||||
- Definition Carrying value as of the balance sheet date of obligations incurred through that date and payable for testing and laboratory materials from suppliers. No definition available.
|
X | ||||||||||
- Definition Amount of expenses not otherwise itemized or categorized in the footnotes to the financial statements that have been incurred but not yet paid, due within one year or the normal operating cycle, if longer. No definition available.
|
X | ||||||||||
- Definition Carrying value as of the balance sheet date of obligations incurred through that date and payable to insurance entities to mitigate potential loss from various risks or to satisfy a promise to provide certain coverage's to employees. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services. Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). No definition available.
|
X | ||||||||||
- Definition Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|